Chargement en cours...
Response to comment on 'Palovarotene reduces heterotopic ossification in juvenile FOP mice but exhibits pronounced skeletal toxicity'
We respond to concerns expressed by Pacifici and Shore (2019) about a recent paper (Lees-Shepard and Goldhamer, 2018a) in which we reported that the drug palovarotene can have severe side effects in a mouse model of fibrodysplasia ossificans progressiva.
Enregistré dans:
| Publié dans: | eLife |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
eLife Sciences Publications, Ltd
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6353591/ https://ncbi.nlm.nih.gov/pubmed/30698142 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7554/eLife.43928 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|